Greykasell Wealth Strategies, Inc. Novartis Ag Transaction History
Greykasell Wealth Strategies, Inc.
- $237 Billion
- Q3 2025
A detailed history of Greykasell Wealth Strategies, Inc. transactions in Novartis Ag stock. As of the latest transaction made, Greykasell Wealth Strategies, Inc. holds 2,013 shares of NVS stock, worth $254,785. This represents 0.11% of its overall portfolio holdings.
Number of Shares
2,013
Previous 2,013
-0.0%
Holding current value
$254,785
Previous $244 Million
5.97%
% of portfolio
0.11%
Previous 0.12%
Shares
1 transactions
Others Institutions Holding NVS
# of Institutions
1,592Shares Held
136MCall Options Held
1.72MPut Options Held
1.7M-
Dodge & Cox San Francisco, CA10.6MShares$1.35 Billion0.78% of portfolio
-
Primecap Management CO Pasadena, CA10.4MShares$1.32 Billion1.03% of portfolio
-
Dimensional Fund Advisors LP Austin, TX9.06MShares$1.15 Billion0.26% of portfolio
-
Morgan Stanley New York, NY7.56MShares$957 Million0.06% of portfolio
-
Ken Fisher Fisher Asset Management, LLC | Camas, Wa7.12MShares$901 Million0.35% of portfolio
About NOVARTIS AG
- Ticker NVS
- Exchange OTC
- Sector Healthcare
- Industry Drug Manufacturers—General
- Shares Outstandng 2,151,000,064
- Market Cap $272B
- Description
- Novartis AG researches, develops, manufactures, and markets healthcare products worldwide. The company operates through two segments, Innovative Medicines and Sandoz. The Innovative Medicines segment offers prescription medicines for patients and healthcare providers. It also provides ophthalmology, neuroscience, immunology, hepatology, dermatol...